Purdue Pharma Edits Public Service Ad In Washington Post
Did OxyContin maker admit opioids can be dangerous even when patients take them as prescribed — then walk it back?
The independent source for health policy research, polling, and news.
301 - 320 of 382 Results
Did OxyContin maker admit opioids can be dangerous even when patients take them as prescribed — then walk it back?
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
KHN senior correspondent Fred Schulte talks about a cache of files detailing Purdue Pharma’s early OxyContin marketing plan.
The nation’s effort to combat this public health crisis could get caught in the crossfire of the Trump administration’s trade policies.
The CEO of Comprehensive Pain Specialists was indicted in April. Now the group is closing clinics across several states.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
As the opioid epidemic rages, a Johns Hopkins surgeon and researcher is leading an effort to curb overprescribing by offering procedure-specific guidelines to ensure that post-surgical patients leave the hospital with enough, but not too much, pain medication.
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
New Hampshire parents who are trying to overcome opioid abuse face a ticking clock and limited state resources to try to keep their parental rights.
An inside look at how Purdue Pharma pushed OxyContin despite risks of addiction and fatalities.
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call discuss President Donald Trump’s proposals to control prescription drug prices and the efforts to sell the plan to lawmakers and the public. Also, Rovner interviews emeritus law professor Timothy Jost about the state of the Affordable Care Act.
Opioid addiction is often portrayed as a white problem, but overdose rates are now rising faster among Latinos and blacks. Cultural and linguistic barriers may put Latinos at greater risk.
Last month, U.S. Surgeon General Jerome Adams urged more Americans to carry and learn to use naloxone, which can save someone from an opioid overdose. But the drug, brand-name Narcan, can be difficult to get and expensive.
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
Research is just beginning on infants born with neonatal abstinence syndrome, and doctors are optimistic that normal development is possible. Monitoring the families and making sure parents are treated for addiction is key.
A device called the Bridge is supposed to mitigate the misery of withdrawal sickness, but scientific evidence doesn't yet show that it works.
© 2026 KFF